Safety and feasibility of a novel 25-gauge biodegradable implant of dexamethasone for treatment of macular edema associated with retinal vein occlusion: a phase i clinical trial

Conclusion: In this Phase I study demonstrating the feasibility of intravitreal DDS-25 insertion for the treatment of decreased vision due to macular edema associated with retinal vein occlusion, no safety concerns were observed. A larger prospective randomized study with longer follow-up is warranted to confirm these findings.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Brief report Source Type: research